SARS News and Research

RSS

Novel strategy to produce SARS-CoV-2 nucleocapsid protein for serological testing

New research discusses an alternative method of purifying the SARS-CoV-2 N protein using only metal exchange chromatography and denaturing conditions.

18 Nov 2021

Study finds no strong evidence that COVID-19 vaccination is linked to menstrual changes

A new study reports on the incidence of changes in menstruation in women who have received the COVID-19 vaccine.

18 Nov 2021

SARS-CoV-2 infection and reinfection in farmed mink

A new study finds that farmed mink acquire SARS-CoV-2 infection, freely transmit it among themselves, and were reinfected, despite being seropositive.

18 Nov 2021

What is the global prevalence of long COVID?

This study aims to provide a comprehensive synthesis of information on the prevalence and symptoms of PASC.

18 Nov 2021

Simulating SARS-CoV-2 transmission dynamics for reopening European universities

Researchers from Graz University of Technology modeled transmission dynamics in a European university.

18 Nov 2021

Structure of SARS-CoV-2 spike protein postfusion

A new study published in PNAS proposes a higher resolution in situ structure of the SARS-CoV-2 spike protein in its postfusion state.

18 Nov 2021

Triad of cytokines associated with long COVID

A new study suggests a trio of cytokines — IL-1ß, IL-6, and TNF-α — are associated with long COVID symptoms.

18 Nov 2021

COVID-19 in open schools and preschools in Norway

A new study describes the cases and outbreaks of COVID-19 in schools and preschools in Norway to evaluate the strategy of keeping them open with control measures in place.

18 Nov 2021

Blood proteomic survey in undiagnosed population with COVID-19

In this study, scientists have profiled 276 circulating proteins that are associated with cardiovascular and metabolic functions.

18 Nov 2021

Real-world effectiveness and safety of COVID-19 vaccines

A new study published in Infectious Diseases of Poverty aimed to systematically evaluate the effectiveness and safety of the COVID-19 vaccines in the real world as well as establish a reliable evidence-based basis to determine the actual protective effect of the COVID-19 vaccines, especially considering the new waves of infection brought about by the variants.

18 Nov 2021

Evidence of significantly greater protection against COVID from BNT162b2 boosters

In a new study, researchers from several British institutes estimated the effectiveness of booster vaccination against symptomatic COVID-19 in adults aged 50 years and older.

18 Nov 2021

Toll-like receptor 2 - novel target for improved COVID-19 vaccines

In a new study, researchers from French and American institutes analyzed at a molecular level the interaction between SARS-CoV-2 E protein and human TLR2.

17 Nov 2021

Study shows neutralizing capacity of monoclonal antibodies against SARS-CoV-2 variants of concern

Canadian public health researchers recently published a study in the journal Antiviral Research wherein they described generating a panel of murine hybridomas recognizing SARS-CoV-2 spike protein or nucleoprotein, capable of neutralizing the SARS-CoV-2 variants of concern, proving their therapeutic potential.

17 Nov 2021

SARS News and Research

Novel strategy to produce SARS-CoV-2 nucleocapsid protein for serological testing

Study finds no strong evidence that COVID-19 vaccination is linked to menstrual changes

SARS-CoV-2 infection and reinfection in farmed mink

What is the global prevalence of long COVID?

Simulating SARS-CoV-2 transmission dynamics for reopening European universities

Structure of SARS-CoV-2 spike protein postfusion

Triad of cytokines associated with long COVID

COVID-19 in open schools and preschools in Norway

Blood proteomic survey in undiagnosed population with COVID-19

Real-world effectiveness and safety of COVID-19 vaccines

Evidence of significantly greater protection against COVID from BNT162b2 boosters

Toll-like receptor 2 - novel target for improved COVID-19 vaccines

Study shows neutralizing capacity of monoclonal antibodies against SARS-CoV-2 variants of concern

The antiviral function of BET protein against SARS-CoV-2 infection

Vaccines and boosters remain strong against current SARS-CoV-2 variants

New method to identify potential false-positive COVID-19 results

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

P681H mutation helps SARS-CoV-2 VOCs replicate faster and resist innate immunity

Lung autopsies provide a clearer picture of how SARS-CoV-2 virus spreads and causes damage

Study uncovers the herpes virus' strategy for infecting the nervous system

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News